207277-66-5

Usage

Uses

Used in Pharmaceutical Industry:
(-)-3(S)-Phenyl-4(R)-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-3,4-dihydro-2H-1-benzopyran-7-ol is used as a pharmaceutical compound for its potential medicinal applications. Its unique stereochemistry plays a crucial role in its activity and function, making it a valuable candidate for the development of new drugs and therapies.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (-)-3(S)-Phenyl-4(R)-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-3,4-dihydro-2H-1-benzopyran-7-ol serves as a key molecule for research and development. Its complex structure and stereochemistry allow scientists to explore its interactions with biological targets, potentially leading to the discovery of new treatments and therapeutic agents.

Upstream product

• 1133446-52-2 (+)-cis-7-methoxy-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]-phenyl}chromane (+)-O,O'-ditoluoyltartrate 
• 18196-29-7 (+/-)-cis-7-methoxy-3-phenyl-4-(4-(2-pyrrolidinoethoxy)phenyl)chromane 
• 33257-83-9 4-(4-hydroxyphenyl)-7-methoxy-3-phenyl-2H-chromen-2-one 
• 13417-73-7 4-(p-hydroxyphenyl)-3-phenyl-7-methoxy-2H-chromene 
• 7440-44-0 pyrographite 
• 275386-21-5 (+/-)-trans-7-Methoxy-3-phenyl-4-(4-(2-pyrrolidinoethoxy)phenyl)chromane 

Relevant academic research and scientific papers

NOVEL (-)-ENANTIOMERS OF CIS-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES

The present invention relates to therapeutically active compounds of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related

Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor

The syntheses and in vitro pharmacological evaluation of a number of cis-3,4-diaryl-hydroxy-chromanes are reported, along with the results of a thorough in vivo profiling of the tissue-selective estrogen partial-agonist NNC 45-0781 [3, (-)-(3S,4R)-7-hydro

cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related di

Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

The present invention relates to therapeutically active compounds of formula I STR1 a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen relat